Shuttle Pharmaceuticals ... (SHPH)
NASDAQ: SHPH
· Real-Time Price · USD
3.85
-0.07 (-1.79%)
At close: Oct 15, 2025, 3:59 PM
3.73
-3.12%
After-hours: Oct 15, 2025, 05:29 PM EDT
Shuttle Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | 5.46K | 6.81K | 5.97K | 60.83K |
Gross Profit | -5.46K | -6.81K | -66.83K | -60.83K |
Operating Income | -7.7B | -5.89M | -2.34M | -1.74M |
Interest Income | 38.14K | 79.12K | n/a | n/a |
Pretax Income | -9.14B | -6.59M | -5M | -1.15M |
Net Income | -9.14B | -6.59M | -3.1M | -1.15M |
Selling & General & Admin | 1.39B | 1.05M | 1.07M | 721.18K |
Research & Development | 3.62M | 3.52M | 1.05M | 1.02M |
Other Expenses | -1.39B | 1.32M | 224.72K | -60.83K |
Operating Expenses | 7.69M | 5.89M | 2.34M | 1.68M |
Interest Expense | 1.36M | 2.6M | 670.61K | 50.79K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 7.7M | 5.89M | 2.34M | 1.74M |
Income Tax Expense | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 10.32M | 15.91M | 10.35M | 13.59M |
Shares Outstanding (Diluted) | 10.32M | 15.91M | 10.35M | 13.59M |
EPS (Basic) | -885.73 | -0.41 | -0.3 | -0.09 |
EPS (Diluted) | -885.73 | -0.41 | -0.3 | -0.09 |
EBITDA | -7.78M | -3.99M | -4.32M | -1.04M |
EBIT | -7.78M | -4M | -4.33M | -1.1M |
Depreciation & Amortization | 5.46K | 6.81K | 5.97K | 60.83K |
Source: Financial Modeling Prep. Financial Sources.